Foghorn Therapeutics Inc. financial data

Symbol
FHTX on Nasdaq
Industry
Pharmaceutical Preparations
Location
500 Technology Square, Suite 700, Cambridge, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 460 % -32.1%
Debt-to-equity -524 % -115%
Return On Equity 132 %
Return On Assets -31.1 % -15.5%
Operating Margin -303 % +49%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 42.6 M shares +1.82%
Common Stock, Shares, Outstanding 42.6 M shares +1.82%
Entity Public Float 200 M USD -40.4%
Common Stock, Value, Issued 4 K USD 0%
Weighted Average Number of Shares Outstanding, Basic 42.4 M shares +1.48%
Weighted Average Number of Shares Outstanding, Diluted 42.4 M shares +1.48%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 33.9 M USD +64.4%
Research and Development Expense 105 M USD -5.27%
General and Administrative Expense 31.4 M USD -2.27%
Operating Income (Loss) -103 M USD +16.2%
Nonoperating Income (Expense) 13.5 M USD +25.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -89.3 M USD +20.2%
Income Tax Expense (Benefit) 3.67 M USD +555%
Net Income (Loss) Attributable to Parent -93 M USD +17.3%
Earnings Per Share, Basic -2.2 USD/shares +18.5%
Earnings Per Share, Diluted -2.2 USD/shares +18.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 79.3 M USD +56.5%
Assets, Current 212 M USD -34%
Operating Lease, Right-of-Use Asset 28.5 M USD -13.2%
Other Assets, Noncurrent 1.05 M USD -55.5%
Assets 255 M USD -31.6%
Accounts Payable, Current 5.63 M USD -22.7%
Employee-related Liabilities, Current 1.62 M USD -3.11%
Accrued Liabilities, Current 6.27 M USD -29.1%
Contract with Customer, Liability, Current 31.5 M USD -5.49%
Liabilities, Current 52.1 M USD -6.69%
Contract with Customer, Liability, Noncurrent 266 M USD -10.8%
Operating Lease, Liability, Noncurrent 34.3 M USD -21.1%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 352 M USD -11.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -497 K USD +82.7%
Retained Earnings (Accumulated Deficit) -497 M USD -23%
Stockholders' Equity Attributable to Parent -97.5 M USD -297%
Liabilities and Equity 255 M USD -31.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -29.3 M USD +5.89%
Net Cash Provided by (Used in) Financing Activities 1.17 M USD +1044%
Net Cash Provided by (Used in) Investing Activities 27.1 M USD -8.17%
Common Stock, Shares Authorized 175 M shares 0%
Common Stock, Shares, Issued 42.6 M shares +1.82%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.08 M USD +31.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 81 M USD +54.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 3.55 M USD
Deferred Tax Assets, Valuation Allowance 143 M USD +27.8%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 154 M USD +23.7%
Operating Lease, Liability 45.1 M USD -12.5%
Payments to Acquire Property, Plant, and Equipment 101 K USD -84.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -90.6 M USD +20.6%
Lessee, Operating Lease, Liability, to be Paid 51.1 M USD -17.2%
Operating Lease, Liability, Current 8.67 M USD +36.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 10.7 M USD +1.82%
Lessee, Operating Lease, Liability, to be Paid, Year One 10.7 M USD +7.43%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6.07 M USD -31.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 10.6 M USD -0.58%
Deferred Tax Assets, Operating Loss Carryforwards 631 K USD -98.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25 M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 10.9 M USD -0.5%
Operating Lease, Payments 10.1 M USD +1.61%
Additional Paid in Capital 400 M USD +4.63%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 3.43 M USD +1.72%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Interest Expense 426 K USD -76.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%